高遷移率族蛋白1(HMGB1)多克隆抗體
Polyclonal Antibody to High Mobility Group Protein 1 (HMGB1)
HMG1; HMG3; SBP1; Sulfoglucuronyl Carbohydrate Binding Protein; Amphoterin; High Mobility Group Box 1 Protein
編號PAA399Ra01
物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
來源多抗制備
宿主兔
效價-
Ig類型IgG
純化方式抗原特異性親和純化
標(biāo)記物無標(biāo)記物
免疫原RPA399Ra01-高遷移率族蛋白1(HMGB1)重組蛋白
緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
性狀液體
濃度0.34mg/ml
且適物種Homo sapiens (Human,人), Mus musculus (Mouse,小鼠)
應(yīng)用WB,IHC
如果抗體需用于流式細胞術(shù),請參見流式抗體。下載英文說明書 中文說明書
規(guī)格20µl100µl 200µl 1ml 10ml
價格¥ 1436
特異性
該抗體是針對HMGB1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別HMGB1。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有明顯的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
參考文獻
雜志 | 參考文獻 |
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis [PubMed: PMC3094252] |
Respiration | Protective Effect of Nicotine on Lipopolysaccharide-Induced Acute Lung Injury in Mice [Karger: 000319151] |
Surgery | Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in Southwest China [Pubmed: 22047946] |
Viral Immunology | Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment? [Wiley: source] |
Chinese Medical Journal | Severity of sepsis is correlated with the elevation of serum high-mobility group box 1 in rats [CMJ: 2009218808935901080] |
Microbiology and Immunology | Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis [PubMed: 23278480] |
ACTA biochimica polonica | High mobility group B1 levels in sepsis and disseminated intravascular coagulation [Actabp: Source] |
Anesthesia and Analgesia | The Inhibitory Effect of Lidocaine on the Release of High Mobility Group Box 1 in Lipopolysaccharide-Stimulated Macrophages [PubMed: 21288974] |
Rheumatology International | Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life [PubMed: 23143556] |
Inflammation Research | Mammalian target of rapamycin complex 2 regulates inflammatory response to stress [PubMed: 22899279] |
Acta Biochimica et Biophysica Sinica | IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs [PubMed: 22782142] |
LabVest | The suppression of TRIM21 and the accumulation of IFN-α play crucial roles in the pathogenesis of osteonecrosis of the femoral head. [PubMed: 22825687] |
Biomark Insights | Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism [PubMed: PMC3623607] |
Evidence-based Complementary and Alternative Medicine | ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression [PubMed: PMC3770047] |
Exp Ther Med | Correlation between serum high-mobility group box-1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease [Pubmed: 23935732] |
International of Rheumatic disesases | Serum levels of high mobility group box 1 protein and its association with quality of life and psychological and functional status in patients with fibromyalgia [Pubmed: 23901875] |
Surgery | A novel serum marker for biliary tract cancer: Diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) [Pubmed: 24468034] |
Acta Pharmacol Sin. | Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE-/- mice by downregulating the HMGB1-RAGE axis [Pubmed: 23564080] |
BMC pulmonary medicine | Soluble receptor for advanced glycation end-products and progression of airway disease [Pubmed: 24758342] |
Biochemical Pharmacology | Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/HO-1 signals [Pubmed:25896849] |